Virtual health platform for improving care in hemodialysis patients
REVID +: Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform (GoodRENal.eu)
This study is testing a virtual health program to see if it can help people on hemodialysis improve their exercise, nutrition, and mental well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Cardenal Herrera University Academic / other |
| Locations | 8 sites (Leuven and 7 other locations) |
| Trial ID | NCT04823286 on ClinicalTrials.gov |
What this trial studies
This project aims to enhance the quality of life for patients undergoing hemodialysis by integrating a virtual health platform that focuses on exercise, nutrition, and psychological support. It addresses the common challenges faced by end-stage renal disease patients, such as frailty, malnutrition, and mental health issues. The program will explore barriers and facilitators to implementing these interventions, ultimately promoting healthier lifestyles and improving patient outcomes. The study will involve patients who are medically stable and able to walk, utilizing a holistic approach to care.
Who should consider this trial
Good fit: Ideal candidates for this study are patients on hemodialysis who are medically stable and can walk at least a few steps.
Not a fit: Patients with recent myocardial infarctions, unstable angina, significant cognitive impairments, or life expectancies of less than six months may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the health-related quality of life and functional capacity of hemodialysis patients.
How similar studies have performed: Other studies have shown positive outcomes with similar holistic approaches, indicating potential for success in this novel intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients on hemodialysis medically stable * Ability to walk to walk at least a few steps, even if walking aids like canes or a walker ar needed * Life expectancy greater than 6 months Exclusion Criteria: * Myocardial infarction in the previous 6 weeks * Angina unstable on exercise or at rest * Brain injury derived from a cardiovascular problem. Cerebral vascular disease such as stroke in the last 6 months or with relevant sequelae in lower limb mobility presenting hemiparesia. * Life expectancy less than 6 months * Cognitive impairment * Language barriers * Illiteracy
Where this trial is running
Leuven and 7 other locations
- KU Leuven — Leuven, Belgium (Suspended)
- Aristotle University of Thessaloniki — Thessaloníki, Greece (Completed)
- Consorci Sanitari de Terrassa — Terrassa, Barcelona, Spain (Recruiting)
- Hospital de Manises — Manises, Valencia, Spain (Completed)
- Universitat de Valencia — Valencia, Spain (Completed)
- Universitat Politécnica de Valéncia — Valencia, Spain (Completed)
- Skane Univeristy Hospital — Lund, Sweden (Terminated)
- Karolinska Institute — Stockholm, Sweden (Completed)
Study contacts
- Principal investigator: Eva SEGURA-ORTÍ — Universidad CEU Cardenal Herrera, UCH CEU
- Study coordinator: Eva SEGURA-ORTÍ, PhD
- Email: eva.segura@gmail.com
- Phone: 00 34 671580094
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.